PATENT CLAIM ANALYSIS

Application Number: 16072638
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to liquid pharmaceutical compositions of a VEGF antagonist for intravitreal administration comprising a histidine buffer, an inorganic salt, a carbohydrate and a polysorbate.

Claim (Index 6):
The method of  claim 1 , wherein the non-ionic surfactant is present in a concentration of from 0.01 to 0.08% (w/v).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15037254', '15190378', '16305987', '14934666', '15623684']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7060294645653158
- 35 USC 102 Novelty (BERT): 0.5314871789805383
- Combined Prediction Score: 0.6885752360068381
- Mean Citation Score: 266.262532
- Max Citation Score: 345.1267
- Similarity Product: 216.1185728333473

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test